PRODUCT UPDATE ON INDIVA LOZENGES
LONDON, ON, March 14, 2023 /PRNewswire/ - Indiva Limited (the "Company" or "Indiva") (TSXV: NDVA), announced that it has received notification from Health Canada (the "Notice") of its determination that certain of its lozenges have been improperly classified as an "extract" rather than an...
Read more »